This inventor holds 1 USPTO granted patent. Top assignee: Technische Hochschule Köln. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Henrik Weber in Pharmaceutical Synthesis
Introduction
Henrik Weber is an accomplished inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of drugs aimed at treating neurodegenerative diseases and psychiatric disorders. His innovative work has led to the creation of a unique patent that showcases his expertise in this vital area of research.
Latest Patents
Henrik Weber holds a patent for "Arylcyclohexylamine derivatives and process for preparing same." This invention relates to the technical field of pharmaceutical synthesis and the development of drugs. The patent outlines a process for preparing cyclic 2-amino-1-one derivatives, along with the reaction products and intermediates that can be obtained through this process. Furthermore, it discusses pharmaceutical compositions, specifically drugs or medicaments that incorporate these cyclic 2-amino-1-one derivatives, emphasizing their use in the prophylactic or therapeutic treatment of diseases affecting the human or animal body.
Career Highlights
Henrik Weber is associated with Technische Hochschule Köln, where he continues to advance his research in pharmaceutical sciences. His work is characterized by a commitment to improving drug development processes and enhancing therapeutic options for patients suffering from complex health conditions.
Collaborations
Henrik collaborates with Sherif El Sheikh, a fellow researcher, to further explore innovative solutions in the pharmaceutical field. Their combined expertise contributes to the advancement of knowledge and technology in drug synthesis.
Conclusion
Henrik Weber's contributions to pharmaceutical synthesis through his patent and collaborative efforts highlight the importance of innovation in addressing critical health challenges. His work exemplifies the potential of scientific research to improve the quality of life for individuals affected by neurodegenerative diseases and psychiatric disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile